Humblet L, Collignon P, Joris H, Kulbertus H, Primo G
Arch Mal Coeur Vaiss. 1976 Jul;69(7):721-9.
This is a study of 85 valve replacements by mechanical prostheses, 41 of which were in the aortic position and 44 in the mitral position. The results were analysed from the standpoint of the immediate and late mortality, the morbidity, and thrombo-embolic complications. The influence of the severity factors (NYHA classification) on the operative risk and the late mortality has been evaluated. The maximum follow-up period was 8 years for the aortic replacements and 7 years for the mitral replacements. Actuarial graphs show that there is a 78.3% survival for aortic valve replacement and a 66% survival for mitral valve replacement. We feel that the shape of the survival curves is greatly influenced by the size of population studied. As soon as a plateau appears, the significance of the analysis is in doubt. It seems to us that calculation of the degree of confidence is essential if the good quality of the long-term results is not to be overestimated. The results of surgery must be assessed by comparing the survival curves of the operated patients with those of non-operated patients with the same risk factors. The conclusion emerges that prosthetic replacement of the mitral and aortic valves markedly improves the life expectancy of stage IV patients. We can see no indication for early surgery on the aortic valve. On the other hand, mitral valve replacement should be undertaken on stage III patients so that those with a poor life expectancy can be offered a better outlook. The way in which the mitral and aortic valve disorders carry a much greater mortality after the 6th decade should induce us to bring forward the indications for surgery in this age group in spite of the slightly greater immediate and late risk from operating on patients of this age.
这是一项对85例机械瓣膜置换术的研究,其中41例为主动脉瓣置换,44例为二尖瓣置换。从近期和远期死亡率、发病率以及血栓栓塞并发症的角度对结果进行了分析。评估了严重程度因素(纽约心脏协会分级)对手术风险和远期死亡率的影响。主动脉瓣置换的最长随访期为8年,二尖瓣置换为7年。精算图表显示,主动脉瓣置换术后的生存率为78.3%,二尖瓣置换术后为66%。我们认为生存曲线的形状在很大程度上受所研究人群规模的影响。一旦出现平台期,分析的意义就值得怀疑。在我们看来,如果要不高估长期结果的良好质量,计算置信度是必不可少的。手术结果必须通过将手术患者的生存曲线与具有相同危险因素的未手术患者的生存曲线进行比较来评估。得出的结论是,二尖瓣和主动脉瓣的人工瓣膜置换术显著提高了IV期患者的预期寿命。我们看不到对主动脉瓣进行早期手术的指征。另一方面,对于III期患者应进行二尖瓣置换术,以便为预期寿命较差的患者提供更好的前景。二尖瓣和主动脉瓣疾病在60岁以后的死亡率要高得多,这一情况应促使我们尽管对这个年龄段的患者进行手术的近期和远期风险略高,但仍要提前这个年龄段的手术指征。